Quality Evaluation Considerations for Stem Cell-Derived Extracellular Vesicles-Based Therapeutic Products in China

Area of Science:

• Biotechnology
• Regenerative Medicine
• Nanomedicine

Background:

• Stem cell therapy is under clinical investigation in China for intractable diseases.
• Stem cell-derived extracellular vesicles (EVs) offer therapeutic potential comparable to parent stem cells.
• Significant progress has been made in the development and large-scale production of EVs.

Purpose of the Study:

• To propose a comprehensive quality evaluation framework for stem cell-derived EV-based therapeutic products.
• To address the lack of specific regulatory guidelines for EVs in China.
• To provide a reference for researchers and developers in the field.

Main Methods:

• Review of biological properties of EVs.
• Analysis of recent research advances in EV therapy.
• Evaluation of current understanding of EV mechanisms of action.
• Assessment of manufacturing processes and quality control strategies.

Main Results:

• A proposed framework for quality evaluation of stem cell-derived EV therapeutics.
• Identification of key considerations for EV product development and regulation.
• Highlighting the need for standardized quality control and evaluation systems.

Conclusions:

• The proposed framework supports the development and regulatory oversight of stem cell-derived EVs in China.
• Standardized quality evaluation is crucial for ensuring the safety and efficacy of EV-based therapies.
• This work aims to facilitate further discussion and promote the establishment of quality standards for EVs.